SCHEMBL5800784

SCHEMBL5800784

COc1ccc(CCC(=S)NCc2ccc(NS(C)(=O)=O)c(F)c2)cc1OC

nearest known ligand 0.68

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801220 0.89 KMT2A (0.56)
SCHEMBL5803995 0.84 TRPV1 (0.56) TRPV1
SCHEMBL5804606 0.81
SCHEMBL5804350 0.81 TRPV1 (0.64) TRPV1
SCHEMBL5800999 0.81 TRPV1 (0.77) TRPV1
SCHEMBL5801184 0.76 TRPV1 (0.59) TRPV1
SCHEMBL27568597 0.76 TRPV1 (0.68) TRPV1
SCHEMBL4887198 0.75
SCHEMBL5802713 0.74 TRPV1 (0.57) TRPV1
SCHEMBL5276015 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006098554-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-21 WO claimed
WO-2006098554-A1 NOVEL COMPOUNDS, ISOMER THEREOF OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2006-09-21 WO disclosed